Home/Filings/4/0001415889-25-008552
4//SEC Filing

Lin Xichen 4

Accession 0001415889-25-008552

CIK 0001888886other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 8:45 PM ET

Size

8.0 KB

Accession

0001415889-25-008552

Insider Transaction Report

Form 4
Period: 2025-03-15
Lin Xichen
CHIEF SCIENTIFIC OFFICER
Transactions
  • Award

    Ordinary Shares

    2025-03-15+80,829166,536 total
  • Award

    Employee Stock Option (right to buy)

    2025-03-15+196,386196,386 total
    Exercise: $7.02Exp: 2035-03-15Ordinary Shares (196,386 underlying)
Footnotes (4)
  • [F1]The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
  • [F2]Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates.
  • [F3]The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.
  • [F4]1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.

Issuer

Structure Therapeutics Inc.

CIK 0001888886

Entity typeother

Related Parties

1
  • filerCIK 0001962926

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 8:45 PM ET
Size
8.0 KB